Cable company Qian Fang: aftertaste
Release time:
2020-08-14
cable company Qian Fang: aftertaste
Looking at the mobile phone photo album made by myself and aftertaste the interesting sports meeting that ended not long ago, there are exciting pictures in my mind, neat teams, high-spirited players, hard work and sweat on the sports field, cheers and cheers on the sports field... Always reverberating in my mind, making people unsatisfied!
In the tug-of-war in the collective project, our first opponent is Akohama Pharmaceutical Factory, the former champion team, and many of the team members are old employees of our cable company. After the result of the draw came out, the main players of the two teams hugged each other, patted their shoulders and exchanged pleasantries. It looked really kind, but when they arrived on the field, the atmosphere immediately changed-Jin Yonghong, the main force of Qiubin Factory, grabbed the rope with both hands like iron tongs, squatted steadily and leaned back. Wang Debo, the main force of our team, was not willing to show weakness, and was holding tight the rope. The rope deviated a little bit from the center point. Everyone's palms were red by the rope, and the sweat on their foreheads rolled down. The leaders on both sides followed the footsteps of their own team, cheering with cheerleaders. One side was "1. 2. Three", the other was "Come on, come on", one after another. In the end, the center of the rope crossed the red line on the opponent's side, and Akohama Pharmaceutical Factory took the first game. In the second game after the exchange of positions, the same scene was played again. Akihama factory won, we lost, but we all laughed happily...
Although we lost in the collective project, we were fruitful in the individual project. Sun Genfa is a pair wringer in the city's telephone cable team. He usually works very hard. This time he came to the interesting bowling arena. He unhurriedly picked up the small ball, aimed and threw it hard. The ball rolled straight to the middle of the bowling array. Wow! Pour it all! There was a scream all at once. Sun Genfa was the only player who knocked down all the bowlers in this game. We all gave him a thumbs up, but he smiled shyly with his head down...
Our female players are even more women than men. Shen Yanzhen, Wu Shujuan, and Shao Fengxiang won the first and 3. places for women to cross the river by touching stones respectively. In the competition, they gave full play to their respective ingenuity and achieved good results. In their work, they are more serious and responsible. Excellent employees who are down-to-earth and willing to work.
Looking back on this sports meeting, not only the project was easy and interesting, it deepened the friendship between brothers and colleagues, but also embodied the spirit of teamwork and hard work in the competition. This kind of spirit is the enterprise spirit of "unity and struggle" and "forever climbing the peak!
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page